Diagnosis and staging of prostatic carcinoma should be considered in men in
whom treatment with curative intent is possible. The primary tools for det
ection of cancer are digital rectal examination (DRE) and serum prostate-sp
ecific antigen (PSA), whereas transrectal ultrasonography is best used to g
uide the needle for biopsy. Staging should be based on the TNM system. The
most reliable staging methods include a combination of DRE, PSA and systema
tic biopsies for local tumor extension, pelvic lymphadenectomy for regional
lymph nodes, and PSA and bone scintigraphy for distant metastases. Compute
d tomography a nd magnetic resonance imaging a re not necessary in most cas
es. Copyright (C) 1999 S. Karger AG, Basel.